- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04067687
Home Visit Intervention in Pediatric Palliative Care
December 6, 2019 updated by: Murti Andriastuti, Doctor, Indonesia University
Palliative Intervention to Improve Quality of Life in Children With Cancer: A Randomized Controlled Trial
A randomized controlled trial to compare the quality of life between participants who were given palliative care (a 3-month home visit) and those who were not (intervention vs control group) was conducted.
Participants consisted of children with cancer aged 2-18 years old.
A two-way communication between a trained health worker and participants with or without their parents were conducted as the intervention (report by proxy or self-report).
Interventions were given in 6 sessions (1 session every 2 weeks) focusing on problems solving education, symptoms management, self-care, communication, decision making, and long-term care plan assistance.
In the first and twelfth week of the intervention, all participants were assessed with the Pediatric Quality of Life Inventory (PedsQLTM) questionnaire cancer module 3.0.
Symptomps intensityof anorexia, sleep diturbance, and pain will be asessed in each visit.
Participants were followed, Emergency Room (ER) admissions were recorded during follow up period.
During the follow up period, ER admissions were recorded further.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jakarta, Indonesia, 10430
- Cipto Mangunkusumo Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 18 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Child age 2-18 years old with malignancies who undergo treatments at the Department of Child Health of Cipto Mangunkusumo Hospital, during the study period.
- All participants who meet the criteria to get palliative care, participants with a total score ≥ 4 based on palliative screening form.
- Participants and or parents agree to be enrolled in study
Exclusion Criteria:
- Patients who live outside Jakarta and therefore unreachable to get palliative intervention
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Control
No palliative home visit intervention
|
|
EXPERIMENTAL: Intervention
Palliative home visit intervention
|
a 3-month home visit, providing two-way communication between a trained health worker and patients with or without their parents were conducted as the intervention (report by proxy or self-report).
Interventions were given in 6 sessions (1 session every 2 weeks) focusing on problems solving education, symptoms management, self-care, communication, decision making, and long-term care plan assistance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life cancer child
Time Frame: at the end of 3 months follow up
|
Measured using PedsQLTM cancer module 3.0 that consisted of eight dimension.
Each dimension consisted of several items to be answered.
Item scaling was answered in 5-point Likert scale from 0 (Never) to 4 (Almost always).
Scores are transformed to a 0 to 100 scale.
Items are reversed scored and linearly transformed to a 0-100 scale as follows: 0=100, 1=75, 2=50, 3=25, 4=0.
If more than 50% of the items in the scale are missing, the scale scores should not be computed.
Mean score = Sum of the items over the number of items answered.
Total score is acquired by summing of all the items over the number of items answered on all the Scales.Higher scores indicate lower problems.
|
at the end of 3 months follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Emergency room visits
Time Frame: during 3 months follow up
|
Frequency of emergency room visit is recorded during 3-months follow up period.
Total number of emergency rom visits will be summed.
|
during 3 months follow up
|
Symptomps intensity
Time Frame: during 3 months follow up
|
Measured using Edmonton Symptoms Asessment Scale.
The severity at the time of assessment of each symptom is rated from 0 to 10 on a numerical scale, 0 meaning that the symptom is absent and 10 that it is of the worst possible severity.
The patient and family should be taught how to complete the scales.
Mean score is acquired by summing all scores then divided it by total number of assesment.
|
during 3 months follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Murti Andriastuti, Doctor, Indonesia University, Cipto Mangunkusumo Hospital Jakarta
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2019
Primary Completion (ACTUAL)
July 1, 2019
Study Completion (ACTUAL)
September 30, 2019
Study Registration Dates
First Submitted
August 22, 2019
First Submitted That Met QC Criteria
August 22, 2019
First Posted (ACTUAL)
August 26, 2019
Study Record Updates
Last Update Posted (ACTUAL)
December 9, 2019
Last Update Submitted That Met QC Criteria
December 6, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PedPalliative01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Cancer
-
Emory UniversityNational Cancer Institute (NCI)Recruiting
-
Ann & Robert H Lurie Children's Hospital of ChicagoSilicon Valley Community FoundationUnknownCancer | Pediatric CancerUnited States
-
University of BirminghamCompletedCancer | Pediatric ALL | Pediatric Solid Tumor | Pediatric AMLUnited Kingdom, Australia, Netherlands
-
Alexandria UniversityCompletedPediatric Cancer | Invasive CancerEgypt
-
University of California, San DiegoNational Cancer Institute (NCI); Dana-Farber Cancer Institute; University of... and other collaboratorsNot yet recruiting
-
Immune Oncology Research InstituteRecruitingContinuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With DexamethasonePediatric CancerArmenia
-
Connecticut Children's Medical CenterThe Hospital for Sick ChildrenRecruitingPediatric CancerUnited States
-
University of Michigan Rogel Cancer CenterRecruitingPediatric CancerUnited States
-
Erin RowellRecruiting
-
Giselle ShollerRecruiting
Clinical Trials on Palliative home visit
-
The Scientific and Technological Research Council...RecruitingStroke | Caregiver | Home Visit | VirtualTurkey
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA)Completed
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA)Recruiting
-
University of AarhusCompleted
-
University of Southern CaliforniaPatient-Centered Outcomes Research InstituteTerminatedCancer | Chronic Obstructive Pulmonary Disease | Congestive Heart FailureUnited States
-
Brigham and Women's HospitalCompletedA Patient Discharged From an Acute-care Hospital Who Had an Acute IllnessUnited States
-
Insel Gruppe AG, University Hospital BernSwiss National Science Foundation; University of BernCompleted
-
Icahn School of Medicine at Mount SinaiCompleted
-
Johns Hopkins UniversityWithdrawnEngagement, Patient | Utilization, Health Care | No-Show PatientsUnited States
-
Centre Hospitalier Universitaire de NiceFondation Mederic AlzheimerCompletedBehavioral DisorderFrance